Defining structural heart disease in the adult patient: Current scope, inherent challenges and future directions

European Heart Journal, Supplement

Volumn 12, Issue SUPPL. E, 2010, Pages

  Steinberg, Daniel H ^a   Staubach, Stephan ^b   Franke, Jennifer ^b   Sievert, Horst ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b CARDIOVASCULAR CENTER FRANKFURT   (Germany)

Author keywords

Catheter based treatment; Interventional cardiology; Structural heart disease

Indexed keywords

DISOPYRAMIDE; VERAPAMIL;

ADULT; ANNULOPLASTY; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; BRAIN ISCHEMIA; CONGENITAL DISORDER; CONGENITAL HEART MALFORMATION; CONGESTIVE HEART FAILURE; DYSPNEA; ENDOCARDITIS; FATIGUE; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM SEPTUM DEFECT; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE ANEURYSM; HEART LEFT VENTRICLE HYPERTROPHY; HEART SURGERY; HEART VALVE PROSTHESIS; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE SEPTUM DEFECT; HEART VENTRICLE SEPTUM RUPTURE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LUNG BLOOD VOLUME; MIGRAINE; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; PATENT DUCTUS ARTERIOSUS; PATENT FORAMEN OVALE; PERCUTANEOUS THROMBECTOMY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VALVE REPLACEMENT; REVIEW; SINUS VENOSUS; STRUCTURAL HEART DISEASE; THROMBOEMBOLISM;

EID: 77957734005     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/suq012     Document Type: Review

References (53)

1. Rubio-Alvarez V, Limon R, Soni J. [Intracardiac valvulotomy by means of a catheter.]. Arch Inst Cardiol Mex 1953;23:183-192.
2. Webb G, Gatzoulis MA. Atrial septal defects in the adult: recent progress and overview. Circulation 2006;114:1645-1653.
3. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J 1995;130:1083-1088.
4. Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992;86:1902-1908.
5. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, Mattle HP, Meier B. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44:750-758. (Pubitemid 39099567)
6. Thanopoulos BV, Dardas PD, Karanasios E, Mezilis N. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. Catheter Cardiovasc Interv 2006;68:741-746.
7. Wechsler LR. PFO and stroke: what are the data? Cardiol Rev 2008;16:53-57.
8. Steinberg DH, Pichard AD, Satler LF, Slack MC, Wunderlich N, Majunke N, Sievert H. Patent foramen ovale closure: past, present and future. Expert Rev Cardiovasc Ther 2007;5:881-891.
9. Neumayer U, Stone S, Somerville J. Small ventricular septal defects in adults. Eur Heart J 1998;19:1573-1582.
10. Gabriel HM, Heger M, Innerhofer P, Zehetgruber M, Mundigler G, Wimmer M, Maurer G, Baumgartner H. Long-term outcome of patients with ventricular septal defect considered not to require surgical closure during childhood. J Am Coll Cardiol 2002;39:1066-1071.
11. Hijazi ZM, Hakim F, Haweleh AA, Madani A, Tarawna W, Hiari A, Cao QL. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience. Catheter Cardiovasc Interv 2002;56:508-515.
12. Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U. S. registry. J Am Coll Cardiol 2004;43:1257-1263. (Pubitemid 38452604)
13. Holzer R, de Giovanni J, Walsh KP, Tometzki A, Goh T, Hakim F, Zabal C, de Lezo JS, Cao QL, Hijazi ZM. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry. Catheter Cardiovasc Interv 2006;68:620-628.
14. Carlgren LE. The incidence of congenital heart disease in children born in Gothenburg 1941-1950. Br Heart J 1959;21:40-50.
15. Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56, 109 births. Incidence and natural history. Circulation 1971;43:323-332.
16. Pas D, Missault L, Hollanders G, Suys B, De Wolf D. Persistent ductus arteriosus in the adult: clinical features and experience with percutaneous closure. Acta Cardiol 2002;57:275-278.
17. Porstmann W, Wierny L, Warnke H. Closure of persistent ductus arteriosus without thoracotomy. Ger Med Mon 1967;12:259-261.
18. Masura J, Walsh KP, Thanopoulous B, Chan C, Bass J, Goussous Y, Gavora P, Hijazi ZM. Catheter closure of moderate-to large-sized patent ductus arteriosus using the new Amplatzer duct occluder: immediate and short-term results. J Am Coll Cardiol 1998;31:878-882.
19. Bilkis AA, Alwi M, Hasri S, Haifa AL, Geetha K, Rehman MA, Hasanah I. The Amplatzer duct occluder: experience in 209 patients. J Am Coll Cardiol 2001;37:258-261.
20. Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol 2004;44:513-519.
21. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996;61:755-759.
22. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534-542.
23. Block PC, Burstein S, Casale PN, Kramer PH, Teirstein P, Williams DO, Reisman M. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. JACC Cardiovasc Interv 2009;2:594-600.
24. Clift P, Thorne S, de Giovanni J. Percutaneous device closure of a pseudoaneurysm of the left ventricular wall. Heart 2004;90: e62.
25. Harrison W, Ruygrok PN, Greaves S, Wijesinghe N, Charleson H, Wade C, Devlin G. Percutaneous closure of left ventricular free wall rupture with associated false aneurysm to prevent cardioembolic stroke. Heart Lung Circ 2008;17:250-253.
26. Chen YT, Kan MN, Chen JS, Lin WW, Chang MK, Hu WS, Hwang DS, Lee DY, Hwang SL, Chiang BN. Detection of prosthetic mitral valve leak: a comparative study using transesophageal echocardiography, transthoracic echocardiography, and auscultation. J Clin Ultrasound 1990;18:557-561.
27. Linden BC, Schumacher CW, MacIver RH, Mrachek JP, Bianco RW. Paravalvular leaks around prosthetic valves implanted in the mitral position: technical refinements of the ovine model. J Heart Valve Dis 2003;12:400-405.
28. Safi AM, Kwan T, Afflu E, Al Kamme A, Salciccioli L. Paravalvular regurgitation: a rare complication following valve replacement surgery. Angiology 2000;51:479-487.
29. Shapira Y, Hirsch R, Kornowski R, Hasdai D, Assali A, Vaturi M, Sievert H, Hein R, Battler A, Sagie A. Percutaneous closure of perivalvular leaks with Amplatzer occluders: feasibility, safety, and shortterm results. J Heart Valve Dis 2007;16:305-313.
30. Pate GE, Al Zubaidi A, Chandavimol M, Thompson CR, Munt BI, Webb JG. Percutaneous closure of prosthetic paravalvular leaks: case series and review. Catheter Cardiovasc Interv 2006;68:528-533.
31. Crenshaw BS, Granger CB, Birnbaum Y, Pieper KS, Morris DC, Kleiman NS, Vahanian A, Califf RM, Topol EJ. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation 2000;101:27-32.
32. Birnbaum Y, Fishbein MC, Blanche C, Siegel RJ. Ventricular septal rupture after acute myocardial infarction. N Engl J Med 2002;347:1426-1432. (Pubitemid 35239716)
33. Radford MJ, Johnson RA, Daggett WM Jr, Fallon JT, Buckley MJ, Gold HK, Leinbach RC. Ventricular septal rupture: a review of clinical and physiologic features and an analysis of survival. Circulation 1981;64:545-553.
34. Holzer R, Balzer D, Amin Z, Ruiz CE, Feinstein J, Bass J, Vance M, Cao QL, Hijazi ZM. Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: results of a U. S. Registry. Catheter Cardiovasc Interv 2004;61:196-201. (Pubitemid 38160617)
35. Thiele H, Kaulfersch C, Daehnert I, Schoenauer M, Eitel I, Borger M, Schuler G. Immediate primary transcatheter closure of postinfarction ventricular septal defects. Eur Heart J 2009;30:81-88.
36. Martinez MW, Mookadam F, Sun Y, Hagler DJ. Transcatheter closure of ischemic and post-traumatic ventricular septal ruptures. Catheter Cardiovasc Interv 2007;69:403-407.
37. Inoue K, Owaki T, Nakamura T, Kitamura F, Miyamoto N. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg 1984;87:394-402.
38. Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114: e84-e231.
39. Ben Farhat M, Ayari M, Maatouk F, Betbout F, Gamra H, Jarra M, Tiss M, Hammami S, Thaalbi R, Addad F. Percutaneous balloon versus surgical closed and open mitral commissurotomy: seven-year follow-up results of a randomized trial. Circulation 1998;97:245-250.
40. Palacios IF, Sanchez PL, Harrell LC, Weyman AE, Block PC. Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome. Circulation 2002;105:1465-1471.
41. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, Scott C, Schaff HV, Tajik AJ. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005;352:875-883. (Pubitemid 40300296)
42. Masson JB, Webb JG. Percutaneous mitral annuloplasty. Coron Artery Dis 2009;20:183-188.
43. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB. Percutaneous transcatheter implantation of an asortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-3008.
44. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 1995;92:1680-1692.
45. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH III, Spirito P, Ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42:1687-1713. (Pubitemid 37383745)
46. Maron BJ, Maron MS, Wigle ED, Braunwald E. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy. J Am Coll Cardiol 2009;54:191-200.
47. Qin JX, Shiota T, Lever HM, Kapadia SR, Sitges M, Rubin DN, Bauer F, Greenberg NL, Agler DA, Drinko JK, Martin M, Tuzcu EM, Smedira NG, Lytle B, Thomas JD. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 2001;38:1994-2000.
48. Firoozi S, Elliott PM, Sharma S, Murday A, Brecker SJ, Hamid MS, Sachdev B, Thaman R, McKenna WJ. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes. Eur Heart J 2002;23:1617-1624.
49. Oosterhof T, Hazekamp MG, Mulder BJ. Opportunities in pulmonary valve replacement. Expert Rev Cardiovasc Ther 2009;7:1117-1122.
50. Zhao SH, Yan CW, Zhu XY, Li JJ, Xu NX, Jiang SL, Xu ZY, Wang C, Wu WH, Hai-Bo H, Li SG, Ye ZK, Wang H. Transcatheter occlusion of the ruptured sinus of Valsalva aneurysm with an Amplatzer duct occluder. Int J Cardiol 2008;129:81-85.
51. Girona J, Marti G, Betrian P, Gran F, Casaldaliga J. Percutaneous embolization of vascular fistulas using coils or Amplatzer vascular plugs. Rev Esp Cardiol 2009;62:765-773.
52. Hudson PA, Eng MH, Kim MS, Quaife RA, Salcedo EE, Carroll JD. A comparison of echocardiographic modalities to guide structural heart disease interventions. J Interv Cardiol 2008;21:535-546.
53. Cubeddu RJ, Inglessis I, Palacios IF. Structural heart disease interventions: an emerging discipline in cardiovascular medicine. J Invasive Cardiol 2009;21:478-482.